VeriChip Corporation has selected Raytheon Microelectronics España/ECLAN for the production of the company’s implantable microchips, including the chip used in its HealthLink patient identification system, its new eight millimeter microchip for use in Medical Components Inc.’s vascular access medical devices, and its glucose-sensing RFID microchip under development with RECEPTORS LLC.
In December 2008, VeriChip purchased all intellectual property related to its implantable RFID business line from Digital Angel Corporation and canceled its manufacturing relationship. After searching for a new manufacturing partner, VeriChip landed on ELCAN Optical Technologies, a provider of optical and electronic solutions for medical, defense & security and commercial customers, and part of the Raytheon Network Centric Systems group of companies.
Latest from Today's Medical Developments
- Cirtec Medical's growth promises faster, cost-effective solutions for customers
- Revolutionizing automation: Creform's made in the USA AGVs
- #64 - Manufacturing Matters: Automation offerings with Visual Components
- Insight Surgery expands U.S. presence with new manufacturing facilities
- Is your shopfloor connected? The importance of Industry 4.0 in manufacturing
- Okuma: Extraordinary Starts Where Limits End
- Three pillars of supply chain performance: Insights from LMA Consulting
- Take a lunch break, expand your manufacturing knowledge
